Report cover image

Global Alpha N-Acetylglucosaminidase Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 198 Pages
SKU # APRC20560783

Description

Summary

According to APO Research, The global Alpha N-Acetylglucosaminidase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alpha N-Acetylglucosaminidase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alpha N-Acetylglucosaminidase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Alpha N-Acetylglucosaminidase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Alpha N-Acetylglucosaminidase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Alpha N-Acetylglucosaminidase include UniQure N.V., Laboratorios Del Dr. Esteve S.A., Dorphan S.A., BioMarin Pharmaceutical Inc., Alexion Pharmaceuticals, Inc. and Abeona Therapeutics, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Alpha N-Acetylglucosaminidase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Alpha N-Acetylglucosaminidase, also provides the sales of main regions and countries. Of the upcoming market potential for Alpha N-Acetylglucosaminidase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alpha N-Acetylglucosaminidase sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Alpha N-Acetylglucosaminidase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Alpha N-Acetylglucosaminidase sales, projected growth trends, production technology, application and end-user industry.

Alpha N-Acetylglucosaminidase Segment by Company

UniQure N.V.
Laboratorios Del Dr. Esteve S.A.
Dorphan S.A.
BioMarin Pharmaceutical Inc.
Alexion Pharmaceuticals, Inc.
Abeona Therapeutics, Inc.
Alpha N-Acetylglucosaminidase Segment by Type

Lesinidase Alfa
EGT-201
BMN-250
ABO-101
Others
Alpha N-Acetylglucosaminidase Segment by Application

In-Patient
Out-Patient
Alpha N-Acetylglucosaminidase Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha N-Acetylglucosaminidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alpha N-Acetylglucosaminidase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha N-Acetylglucosaminidase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Alpha N-Acetylglucosaminidase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Alpha N-Acetylglucosaminidase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alpha N-Acetylglucosaminidase sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Alpha N-Acetylglucosaminidase Market by Type
1.2.1 Global Alpha N-Acetylglucosaminidase Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Lesinidase Alfa
1.2.3 EGT-201
1.2.4 BMN-250
1.2.5 ABO-101
1.2.6 Others
1.3 Alpha N-Acetylglucosaminidase Market by Application
1.3.1 Global Alpha N-Acetylglucosaminidase Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Alpha N-Acetylglucosaminidase Market Dynamics
2.1 Alpha N-Acetylglucosaminidase Industry Trends
2.2 Alpha N-Acetylglucosaminidase Industry Drivers
2.3 Alpha N-Acetylglucosaminidase Industry Opportunities and Challenges
2.4 Alpha N-Acetylglucosaminidase Industry Restraints
3 Global Market Growth Prospects
3.1 Global Alpha N-Acetylglucosaminidase Revenue Estimates and Forecasts (2020-2031)
3.2 Global Alpha N-Acetylglucosaminidase Revenue by Region
3.2.1 Global Alpha N-Acetylglucosaminidase Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Alpha N-Acetylglucosaminidase Revenue by Region (2020-2025)
3.2.3 Global Alpha N-Acetylglucosaminidase Revenue by Region (2026-2031)
3.2.4 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Region (2020-2031)
3.3 Global Alpha N-Acetylglucosaminidase Sales Estimates and Forecasts 2020-2031
3.4 Global Alpha N-Acetylglucosaminidase Sales by Region
3.4.1 Global Alpha N-Acetylglucosaminidase Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Alpha N-Acetylglucosaminidase Sales by Region (2020-2025)
3.4.3 Global Alpha N-Acetylglucosaminidase Sales by Region (2026-2031)
3.4.4 Global Alpha N-Acetylglucosaminidase Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Alpha N-Acetylglucosaminidase Revenue by Manufacturers
4.1.1 Global Alpha N-Acetylglucosaminidase Revenue by Manufacturers (2020-2025)
4.1.2 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Alpha N-Acetylglucosaminidase Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Alpha N-Acetylglucosaminidase Sales by Manufacturers
4.2.1 Global Alpha N-Acetylglucosaminidase Sales by Manufacturers (2020-2025)
4.2.2 Global Alpha N-Acetylglucosaminidase Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Alpha N-Acetylglucosaminidase Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Alpha N-Acetylglucosaminidase Sales Price by Manufacturers (2020-2025)
4.4 Global Alpha N-Acetylglucosaminidase Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Alpha N-Acetylglucosaminidase Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Alpha N-Acetylglucosaminidase Manufacturers, Product Type & Application
4.7 Global Alpha N-Acetylglucosaminidase Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Alpha N-Acetylglucosaminidase Market CR5 and HHI
4.8.2 2024 Alpha N-Acetylglucosaminidase Tier 1, Tier 2, and Tier 3
5 Alpha N-Acetylglucosaminidase Market by Type
5.1 Global Alpha N-Acetylglucosaminidase Revenue by Type
5.1.1 Global Alpha N-Acetylglucosaminidase Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Alpha N-Acetylglucosaminidase Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Type (2020-2031)
5.2 Global Alpha N-Acetylglucosaminidase Sales by Type
5.2.1 Global Alpha N-Acetylglucosaminidase Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Alpha N-Acetylglucosaminidase Sales by Type (2020-2031) & (K Units)
5.2.3 Global Alpha N-Acetylglucosaminidase Sales Market Share by Type (2020-2031)
5.3 Global Alpha N-Acetylglucosaminidase Price by Type
6 Alpha N-Acetylglucosaminidase Market by Application
6.1 Global Alpha N-Acetylglucosaminidase Revenue by Application
6.1.1 Global Alpha N-Acetylglucosaminidase Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Alpha N-Acetylglucosaminidase Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Application (2020-2031)
6.2 Global Alpha N-Acetylglucosaminidase Sales by Application
6.2.1 Global Alpha N-Acetylglucosaminidase Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Alpha N-Acetylglucosaminidase Sales by Application (2020-2031) & (K Units)
6.2.3 Global Alpha N-Acetylglucosaminidase Sales Market Share by Application (2020-2031)
6.3 Global Alpha N-Acetylglucosaminidase Price by Application
7 Company Profiles
7.1 UniQure N.V.
7.1.1 UniQure N.V. Comapny Information
7.1.2 UniQure N.V. Business Overview
7.1.3 UniQure N.V. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 UniQure N.V. Alpha N-Acetylglucosaminidase Product Portfolio
7.1.5 UniQure N.V. Recent Developments
7.2 Laboratorios Del Dr. Esteve S.A.
7.2.1 Laboratorios Del Dr. Esteve S.A. Comapny Information
7.2.2 Laboratorios Del Dr. Esteve S.A. Business Overview
7.2.3 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Portfolio
7.2.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
7.3 Dorphan S.A.
7.3.1 Dorphan S.A. Comapny Information
7.3.2 Dorphan S.A. Business Overview
7.3.3 Dorphan S.A. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Dorphan S.A. Alpha N-Acetylglucosaminidase Product Portfolio
7.3.5 Dorphan S.A. Recent Developments
7.4 BioMarin Pharmaceutical Inc.
7.4.1 BioMarin Pharmaceutical Inc. Comapny Information
7.4.2 BioMarin Pharmaceutical Inc. Business Overview
7.4.3 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Portfolio
7.4.5 BioMarin Pharmaceutical Inc. Recent Developments
7.5 Alexion Pharmaceuticals, Inc.
7.5.1 Alexion Pharmaceuticals, Inc. Comapny Information
7.5.2 Alexion Pharmaceuticals, Inc. Business Overview
7.5.3 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
7.5.5 Alexion Pharmaceuticals, Inc. Recent Developments
7.6 Abeona Therapeutics, Inc.
7.6.1 Abeona Therapeutics, Inc. Comapny Information
7.6.2 Abeona Therapeutics, Inc. Business Overview
7.6.3 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
7.6.5 Abeona Therapeutics, Inc. Recent Developments
8 North America
8.1 North America Alpha N-Acetylglucosaminidase Market Size by Type
8.1.1 North America Alpha N-Acetylglucosaminidase Revenue by Type (2020-2031)
8.1.2 North America Alpha N-Acetylglucosaminidase Sales by Type (2020-2031)
8.1.3 North America Alpha N-Acetylglucosaminidase Price by Type (2020-2031)
8.2 North America Alpha N-Acetylglucosaminidase Market Size by Application
8.2.1 North America Alpha N-Acetylglucosaminidase Revenue by Application (2020-2031)
8.2.2 North America Alpha N-Acetylglucosaminidase Sales by Application (2020-2031)
8.2.3 North America Alpha N-Acetylglucosaminidase Price by Application (2020-2031)
8.3 North America Alpha N-Acetylglucosaminidase Market Size by Country
8.3.1 North America Alpha N-Acetylglucosaminidase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Alpha N-Acetylglucosaminidase Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Alpha N-Acetylglucosaminidase Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Alpha N-Acetylglucosaminidase Market Size by Type
9.1.1 Europe Alpha N-Acetylglucosaminidase Revenue by Type (2020-2031)
9.1.2 Europe Alpha N-Acetylglucosaminidase Sales by Type (2020-2031)
9.1.3 Europe Alpha N-Acetylglucosaminidase Price by Type (2020-2031)
9.2 Europe Alpha N-Acetylglucosaminidase Market Size by Application
9.2.1 Europe Alpha N-Acetylglucosaminidase Revenue by Application (2020-2031)
9.2.2 Europe Alpha N-Acetylglucosaminidase Sales by Application (2020-2031)
9.2.3 Europe Alpha N-Acetylglucosaminidase Price by Application (2020-2031)
9.3 Europe Alpha N-Acetylglucosaminidase Market Size by Country
9.3.1 Europe Alpha N-Acetylglucosaminidase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Alpha N-Acetylglucosaminidase Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Alpha N-Acetylglucosaminidase Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Alpha N-Acetylglucosaminidase Market Size by Type
10.1.1 China Alpha N-Acetylglucosaminidase Revenue by Type (2020-2031)
10.1.2 China Alpha N-Acetylglucosaminidase Sales by Type (2020-2031)
10.1.3 China Alpha N-Acetylglucosaminidase Price by Type (2020-2031)
10.2 China Alpha N-Acetylglucosaminidase Market Size by Application
10.2.1 China Alpha N-Acetylglucosaminidase Revenue by Application (2020-2031)
10.2.2 China Alpha N-Acetylglucosaminidase Sales by Application (2020-2031)
10.2.3 China Alpha N-Acetylglucosaminidase Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Alpha N-Acetylglucosaminidase Market Size by Type
11.1.1 Asia Alpha N-Acetylglucosaminidase Revenue by Type (2020-2031)
11.1.2 Asia Alpha N-Acetylglucosaminidase Sales by Type (2020-2031)
11.1.3 Asia Alpha N-Acetylglucosaminidase Price by Type (2020-2031)
11.2 Asia Alpha N-Acetylglucosaminidase Market Size by Application
11.2.1 Asia Alpha N-Acetylglucosaminidase Revenue by Application (2020-2031)
11.2.2 Asia Alpha N-Acetylglucosaminidase Sales by Application (2020-2031)
11.2.3 Asia Alpha N-Acetylglucosaminidase Price by Application (2020-2031)
11.3 Asia Alpha N-Acetylglucosaminidase Market Size by Country
11.3.1 Asia Alpha N-Acetylglucosaminidase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Alpha N-Acetylglucosaminidase Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Alpha N-Acetylglucosaminidase Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Alpha N-Acetylglucosaminidase Market Size by Type
12.1.1 SAMEA Alpha N-Acetylglucosaminidase Revenue by Type (2020-2031)
12.1.2 SAMEA Alpha N-Acetylglucosaminidase Sales by Type (2020-2031)
12.1.3 SAMEA Alpha N-Acetylglucosaminidase Price by Type (2020-2031)
12.2 SAMEA Alpha N-Acetylglucosaminidase Market Size by Application
12.2.1 SAMEA Alpha N-Acetylglucosaminidase Revenue by Application (2020-2031)
12.2.2 SAMEA Alpha N-Acetylglucosaminidase Sales by Application (2020-2031)
12.2.3 SAMEA Alpha N-Acetylglucosaminidase Price by Application (2020-2031)
12.3 SAMEA Alpha N-Acetylglucosaminidase Market Size by Country
12.3.1 SAMEA Alpha N-Acetylglucosaminidase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Alpha N-Acetylglucosaminidase Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Alpha N-Acetylglucosaminidase Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Alpha N-Acetylglucosaminidase Value Chain Analysis
13.1.1 Alpha N-Acetylglucosaminidase Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Alpha N-Acetylglucosaminidase Production Mode & Process
13.2 Alpha N-Acetylglucosaminidase Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Alpha N-Acetylglucosaminidase Distributors
13.2.3 Alpha N-Acetylglucosaminidase Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.